A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
A5320/V-HICS is an observational, prospective, long-term follow-up study in hepatitis C virus (HCV) monoinfected and HCV/HIV-1...
